In Treatment of Resistance Tuberculosis (TB) In multidrug-resistant (MDR) tuberculosis, the causative bacteria produce an enzyme called beta-lactamase. This enzyme breaks down the antibiotics and makes them ineffective. As a result, the bacteria become resistant to the antibiotic being used for treatment. Byclav CV Syrup comprises two active ingredients, amoxycillin and clavulanic acid. While clavulanic acid stops the enzyme from rendering amoxycillin ineffective, amoxycillin works towards killing the tuberculosis-causing bacteria. This makes the combination of amoxycillin and clavulanic acid an effective treatment for resistant tuberculosis. In Treatment of Bacterial infections Byclav CV Syrup contains two different medicines, Amoxycillin and Clavulanic Acid, that work together to kill the bacteria that cause infections. Amoxycillin works by stopping the growth of bacteria. Clavulanic Acid reduces resistance and enhances the activity of Amoxycillin against bacteria. This combination medicine can be used to treat many different bacterial infections such as ear, sinus, throat, lung, urinary tract, skin, teeth, joints, and bones. It usually makes you feel better within a few days, but you should continue taking it as prescribed even when you feel better to make sure that all bacteria are killed and do not become resistant.
Byclav CV Syrup should be used with caution in patients with kidney disease. Dose adjustment of Byclav CV Syrup may be needed. Please consult your doctor. The dose also needs to be reduced in neonates and infants due to incompletely developed renal function.
Byclav CV Syrup should be used with caution in patients with liver disease. Dose adjustment of Byclav CV Syrup may be needed. Please consult your doctor. Regular monitoring of liver function tests is recommended while you are taking this medicine
FDC Ltd | B-8, MIDC Area, Waluj - 431 136, Dist. Aurangabad, Maharashtra
Marketer/Manufacturer: Abbott || ₹14.5/tablet (25% cheaper)
No customer reviews yet.
FDA approved prescribing information. Levocitrizine; 1995 [revised May 2007]. [Accessed 01 Apr. 2019] (online) Available from: Read More
European Medicne Agency. Revised assessment report: Ambroxol and bromhexine containing medicinal products. 2015. [Accessed 01 Apr. 2019] (online) Available from: Read More
ScienceDirect. Ambroxol. [Accessed 01 Apr. 2019] (online) Available from: Read More
Levocitrizine. Slough, Berkshire: UCB Pharma Limited; 2007 [revised 27 Mar. 2019]. [Accessed 01 Apr. 2019] (online) Available from: Read More
Marketer/Manufacturer: Glaxo SmithKline Pharmaceuticals Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Capri Pharmaceuticals || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Vrovwen Biologics Pvt Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Leeford Healthcare Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Sun Pharmaceutical Industries Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Deon Healthcare || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Aerochem Neutron || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Edymax Lifesciences Private Limited || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Events Pharma || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Iatros Pharmaceuticals Pvt Ltd || ₹14.5/tablet (25% cheaper)